{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:38:35Z","timestamp":1761597515604},"reference-count":44,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T00:00:00Z","timestamp":1402358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2015,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background &amp; Aims<\/jats:title><jats:p>Aim of this study was to investigate whether a potential association exists between several single nucleotide polymorphisms (<jats:styled-content style=\"fixed-case\">SNP<\/jats:styled-content>s) of the <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201028B gene (rs12979860, rs1188122, rs8099917, rs8105790, rs12980275) and <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>sAg persistence. Further, a potential effect on the development of <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>eAg\u2010negative <jats:styled-content style=\"fixed-case\">CHB<\/jats:styled-content> vs. inactive <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>sAg carrier state was assessed in a genotype D <jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content> cohort. A cohort of chronic <jats:styled-content style=\"fixed-case\">HDV<\/jats:styled-content> patients was also used to see if they behave differently compared to chronic <jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content> patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study was conducted in three main patient cohorts: Group 1 consisted of 482 patients with <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>sAg persistence. Of them 143 were inactive carriers, 94 had <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>eAg\u2010positive chronic hepatitis B (<jats:styled-content style=\"fixed-case\">CHB<\/jats:styled-content>) and 245 had anti\u2010<jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>e\u2010positive <jats:styled-content style=\"fixed-case\">CHB<\/jats:styled-content>. Group 2 represents spontaneously recovered <jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content> patients; they were anti\u2010<jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>s and anti\u2010<jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>c positive. Group 3 consisted of 176 chronic hepatitis delta (<jats:styled-content style=\"fixed-case\">CHD<\/jats:styled-content>) patients with antidelta and <jats:styled-content style=\"fixed-case\">HDV<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">RNA<\/jats:styled-content> positivity. <jats:styled-content style=\"fixed-case\">DNA<\/jats:styled-content> sequencing was performed for genotyping.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>When patients with <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>sAg persistence were compared with spontaneously recovered patients, a significant difference was observed for rs8105790 (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.0001), rs12980275 (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.02). Patients who had the <jats:styled-content style=\"fixed-case\">CC<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">TC<\/jats:styled-content> genotype for rs8105790 (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.0001) and <jats:styled-content style=\"fixed-case\">AA<\/jats:styled-content> genotype for 1188122 (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.02) were more likely to be inactive <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>sAg carriers, when inactive <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>sAg carriers were compared with <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>eAg\u2010negative <jats:styled-content style=\"fixed-case\">CHB<\/jats:styled-content> patients. Comparison of <jats:styled-content style=\"fixed-case\">CHD<\/jats:styled-content> patients vs. recovered <jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content> patients was parallel to that of <jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content> persistence vs. recovered <jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content> with similar significant differences in same <jats:styled-content style=\"fixed-case\">SNP<\/jats:styled-content>s.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These results suggest that <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201028B polymorphisms may contribute to <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>sAg persistence and the development of the inactive <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>sAg carrier state.<\/jats:p><\/jats:sec>","DOI":"10.1111\/liv.12595","type":"journal-article","created":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T09:50:01Z","timestamp":1400579401000},"page":"846-853","source":"Crossref","is-referenced-by-count":12,"title":["Interleukin\u201028 gene polymorphisms may contribute to <scp>HB<\/scp>sAg persistence and the development of <scp>HB<\/scp>eAg\u2010negative chronic hepatitis B"],"prefix":"10.1111","volume":"35","author":[{"given":"Senem C.","family":"Karatayl\u0131","sequence":"first","affiliation":[{"name":"Institute of Hepatology Ankara University Ankara Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mithat","family":"Bozday\u0131","sequence":"additional","affiliation":[{"name":"Institute of Hepatology Ankara University Ankara Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ersin","family":"Karatayl\u0131","sequence":"additional","affiliation":[{"name":"Institute of Hepatology Ankara University Ankara Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tu\u011fba","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[{"name":"Institute of Hepatology Ankara University Ankara Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas A.","family":"Husseini","sequence":"additional","affiliation":[{"name":"Institute of Hepatology Ankara University Ankara Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabia","family":"Albayrak","sequence":"additional","affiliation":[{"name":"Biometry Genetics Department Ankara University Ankara Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhip","family":"\u00d6zkan","sequence":"additional","affiliation":[{"name":"Biometry Genetics Department Ankara University Ankara Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeynep","family":"Kalayl\u0131o\u011flu","sequence":"additional","affiliation":[{"name":"Department of Statistics Middle East Technical University Ankara Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kendal","family":"Yal\u00e7\u0131n","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology School of Medicine Dicle University Diyarbakir Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kubilay","family":"\u00c7\u0131nar","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology School of Medicine Ankara University Ankara Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramazan","family":"\u0130dilman","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology School of Medicine Ankara University Ankara Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cihan","family":"Yurdayd\u0131n","sequence":"additional","affiliation":[{"name":"Institute of Hepatology Ankara University Ankara Turkey"},{"name":"Department of Gastroenterology School of Medicine Ankara University Ankara Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,6,10]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature08463"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature08309"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.449"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.10.004"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.447"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni873"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.348"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028798"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2011.0027"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddr301"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.638"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.6.3851-3854.2005"},{"key":"e_1_2_6_14_1","first-page":"LB","article-title":"Association between treatment outcome and rs12979860 polymorphism in HBeAg positive and negative chronic hepatitis B patients treated with Peginterferon alfa\u20102a (Pegasys) and Adefovir (Hepsera); An interim analysis","volume":"52","author":"Takkenberg B","year":"2010","journal-title":"Hepatology"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2011.02507.x"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2011.648952"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-012-1203-y"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1086\/657146"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25749"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.2011.01835.x"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.07.019"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.11.025"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2011.0365"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.02.010"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1621"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.27834"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.33638"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23348"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.06.021"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(03)80457-9"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.80183-0"},{"key":"e_1_2_6_32_1","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1128\/jvi.71.3.2241-2251.1997","article-title":"Human CD4\u00a0+\u00a0 T\u2010cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T\u2010helper cytokine profiles","volume":"71","author":"Nisini R","year":"1997","journal-title":"J Virol"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12139"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2011.02593.x"},{"key":"e_1_2_6_35_1","first-page":"440a","article-title":"Characterization of the inactive HBsAG carrier state with 4\u00a0years of follow\u2010up","volume":"56","author":"Yakut M","year":"2012","journal-title":"Hepatology"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/25.22.4692"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-004-0363-2"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21077"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.128496"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.23740"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.20086"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026620"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1159\/000342526"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit121"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-011-9297-4"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fliv.12595","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fliv.12595","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/liv.12595","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T17:40:06Z","timestamp":1696268406000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/liv.12595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,10]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["10.1111\/liv.12595"],"URL":"https:\/\/doi.org\/10.1111\/liv.12595","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,10]]}}}